Home/Filings/4/0001127602-14-026035
4//SEC Filing

CUBIST PHARMACEUTICALS INC 4

Accession 0001127602-14-026035

CIK 0000912183operating

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 4:11 PM ET

Size

24.4 KB

Accession

0001127602-14-026035

Insider Transaction Report

Form 4
Period: 2014-08-19
STEA GREGORY
SVP, Commercial Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2014-08-19$21.56/sh+5,625$121,27523,761 total
  • Exercise/Conversion

    Common Stock

    2014-08-19$42.09/sh+17,500$736,57549,698 total
  • Exercise/Conversion

    Common Stock

    2014-08-19$34.80/sh+8,437$293,56532,198 total
  • Exercise/Conversion

    Common Stock

    2014-08-19$41.60/sh+6,764$281,38256,462 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2014-08-195,6250 total
    Exercise: $21.56From: 2010-08-14Exp: 2020-05-14Common Stock (5,625 underlying)
  • Sale

    Common Stock

    2014-08-19$65.88/sh38,326$2,524,85218,136 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2014-08-1917,50015,000 total
    Exercise: $42.09From: 2012-05-16Exp: 2022-02-16Common Stock (17,500 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2014-08-198,4378,438 total
    Exercise: $34.80From: 2011-08-13Exp: 2021-05-13Common Stock (8,437 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2014-08-196,76422,545 total
    Exercise: $41.60From: 2013-05-15Exp: 2023-02-15Common Stock (6,764 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    539
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $65.80 to $66.135 The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Option vests 6.25% quarterly over a four-year period.
  • [F3]Options vest 6.25% quarterly over a four-year period.

Issuer

CUBIST PHARMACEUTICALS INC

CIK 0000912183

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000912183

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:11 PM ET
Size
24.4 KB